Cargando…

Super-enhancer-mediated core regulatory circuitry in human cancer

Super-enhancers (SEs) are congregated enhancer clusters with high level of loading of transcription factors (TFs), cofactors and epigenetic modifications. Through direct co-occupancy at their own SEs as well as each other’s, a small set of so called “master” TFs form interconnected core regulatory c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yuan, Jiang, Yan-Yi, Lin, De-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138668/
https://www.ncbi.nlm.nih.gov/pubmed/34093993
http://dx.doi.org/10.1016/j.csbj.2021.05.006
_version_ 1783695856816357376
author Jiang, Yuan
Jiang, Yan-Yi
Lin, De-Chen
author_facet Jiang, Yuan
Jiang, Yan-Yi
Lin, De-Chen
author_sort Jiang, Yuan
collection PubMed
description Super-enhancers (SEs) are congregated enhancer clusters with high level of loading of transcription factors (TFs), cofactors and epigenetic modifications. Through direct co-occupancy at their own SEs as well as each other’s, a small set of so called “master” TFs form interconnected core regulatory circuitry (CRCs) to orchestrate transcriptional programs in both normal and malignant cells. These master TFs can be predicted mathematically using epigenomic methods. In this Review, we summarize the identification of SEs and CRCs in cancer cells, the mechanisms by which master TFs and SEs cooperatively regulate cancer-type-specific expression programs, and the cancer-type- and subtype-specificity of CRC and the significance in cancer biology.
format Online
Article
Text
id pubmed-8138668
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Research Network of Computational and Structural Biotechnology
record_format MEDLINE/PubMed
spelling pubmed-81386682021-06-03 Super-enhancer-mediated core regulatory circuitry in human cancer Jiang, Yuan Jiang, Yan-Yi Lin, De-Chen Comput Struct Biotechnol J Review Article Super-enhancers (SEs) are congregated enhancer clusters with high level of loading of transcription factors (TFs), cofactors and epigenetic modifications. Through direct co-occupancy at their own SEs as well as each other’s, a small set of so called “master” TFs form interconnected core regulatory circuitry (CRCs) to orchestrate transcriptional programs in both normal and malignant cells. These master TFs can be predicted mathematically using epigenomic methods. In this Review, we summarize the identification of SEs and CRCs in cancer cells, the mechanisms by which master TFs and SEs cooperatively regulate cancer-type-specific expression programs, and the cancer-type- and subtype-specificity of CRC and the significance in cancer biology. Research Network of Computational and Structural Biotechnology 2021-05-05 /pmc/articles/PMC8138668/ /pubmed/34093993 http://dx.doi.org/10.1016/j.csbj.2021.05.006 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Jiang, Yuan
Jiang, Yan-Yi
Lin, De-Chen
Super-enhancer-mediated core regulatory circuitry in human cancer
title Super-enhancer-mediated core regulatory circuitry in human cancer
title_full Super-enhancer-mediated core regulatory circuitry in human cancer
title_fullStr Super-enhancer-mediated core regulatory circuitry in human cancer
title_full_unstemmed Super-enhancer-mediated core regulatory circuitry in human cancer
title_short Super-enhancer-mediated core regulatory circuitry in human cancer
title_sort super-enhancer-mediated core regulatory circuitry in human cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138668/
https://www.ncbi.nlm.nih.gov/pubmed/34093993
http://dx.doi.org/10.1016/j.csbj.2021.05.006
work_keys_str_mv AT jiangyuan superenhancermediatedcoreregulatorycircuitryinhumancancer
AT jiangyanyi superenhancermediatedcoreregulatorycircuitryinhumancancer
AT lindechen superenhancermediatedcoreregulatorycircuitryinhumancancer